Showing results (121-130 of 398) with videos related to
Sort By:
Pageof 40
The New England Journal of Medicine|January 17, 2002
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgeryK A Bauer, B I Eriksson, M R Lassen, et al.Chest|January 1, 1994
Efficiency of bronchodilator aerosol delivery to the lungs from the metered dose inhaler in mechanically ventilated patients. A study comparing four different actuator devicesH D Fuller, M B Dolovich, F H Turpie, et al.Chest|December 12, 2003
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studiesAlexander G G Turpie, Bengt I Eriksson, Kenneth A Bauer, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 3, 2009
Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patientsAlexander G G Turpie, Anthonie W A Lensing, Takeshi Fuji, et al.The American Journal of Medicine|March 13, 2018
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous ThromboembolismCraig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.Chest|August 11, 2004
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end pointsAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.The Journal of Arthroplasty|February 1, 2006
Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgeryClifford W Colwell, Lewis M Kwong, Alexander G G Turpie, et al.Journal of the Southern Orthopaedic Association|February 25, 2003
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgeryAlexander G G Turpie, Bengt I Eriksson, Michael R Lassen, et al.Journal of the American College of Cardiology|April 12, 2008
SR123781A: a new once-daily synthetic oligosaccharide anticoagulant for thromboprophylaxis after total hip replacement surgery: the DRIVE (Dose Ranging Study in Elective Total Hip Replacement Surgery) studyMichael R Lassen, Ola Dahl, Patrick Mismetti, et al.Current Opinion in Pulmonary Medicine|August 13, 2002
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolismKenneth A Bauer, Bengt I Eriksson, Michael R Lassen, et al.Pageof 40